v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Net sales $ 315,669 $ 1,135,517 $ 799,727 $ 1,896,789
Cost of sales 229,065 1,102,735 552,841 1,695,321
Gross profit 86,605 32,782 246,886 201,468
Selling, general, and administrative expenses 3,119,519 5,261,960 6,946,984 8,348,471
Operating loss (3,032,915) (5,229,177) (6,700,098) (8,147,004)
Other income (expense):        
Interest income 1,501 24,572 18,977 28,890
Interest expense (12,703) (36,930) (43,927) (53,328)
Other income 1,799,599 223,297 1,804,333 249,791
Other expenses (199,024) (206,960) (442,313) (8,696,361)
Loss before income taxes (1,443,541) (5,225,198) (5,363,029) (16,618,012)
Income tax benefit 439,503 891,817
Net loss (1,004,038) (5,225,198) (4,471,212) (16,618,012)
Attributable to:        
OSR Health, Inc. and subsidiaries (848,905) 331,414 (3,780,366) (11,061,400)
Non-controlling interests (155,133) (5,556,612) (690,846) (5,556,612)
Other comprehensive income for the period, net of tax        
Gain on foreign currency translation (3,152,587) 6,737,816 (9,242,645) 7,204,892
Total comprehensive income(loss) for the period (4,156,625) 1,512,618 (13,713,857) (9,413,120)
Attributable to:        
OSR Health, Inc. and subsidiaries (1,265,985) 4,660,110 (9,694,127) (6,265,628)
Non-controlling interests $ (2,890,640) $ (3,147,492) $ (4,019,730) $ (3,147,492)
Income(loss) per share attributable to OSR Health, Inc. and subsidiaries        
Basic income(loss) per ordinary share (in Dollars per share) $ (0.02) $ 0.02 $ (0.11) $ (0.73)